The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSY.L Regulatory News (SSY)

  • There is currently no data for SSY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

25 May 2011 14:15

RNS Number : 2728H
SciSys PLC
25 May 2011
 

SciSys PLC

 

TRADING STATEMENT

SciSys PLC, AIM stock code: SSY, ('SciSys' or the 'Company') - the supplier of bespoke software systems, IT based solutions and support services to the Media Broadcast, Space, Government & Defence, Environment and Application Support sectors is pleased to release the following trading statement ahead of its AGM on 26 May.

The Directors are happy to report that they currently anticipate results for the first half of 2011 will be consistent with market expectations for the full year.

 

SciSys opened the year with a comfortable order book position of £26.5m and order intake for 2011 to date is in line with expectations.

 

While its trading outlook remains positive, the Company recognises the continuing impact of the UK Government's 2010 spending review on deferrals of potential projects and programmes in the UK public sector.

 

Nevertheless with over 50% of its business derived from outside the UK and with a broad spread of customers in other markets, SciSys believes that it is sufficiently resilient to withstand any adverse conditions in the UK public sector.

 

The Company continues to show healthy cash flows which are reflected in the strength of its balance sheet. The Directors have considered the most appropriate use of surplus cash resources. Pending identification of short term acquisition opportunities, the Directors are pleased to announce that SciSys has agreed to purchase the freehold in its headquarters building, for a consideration of £5.04 million.

 

The Chippenham property provides office accommodation of 44,000 square feet over two storeys and exchange of contracts has occurred with the purchase expected to complete before the end of May 2011.

 

The Company considers that this acquisition will have an immediate positive impact on profitability by removing a substantial rent liability. The property will be sublet on a long term lease to its wholly owned subsidiary company, SciSys UK Ltd, which is currently the primary occupier, and SciSys will also seek to install other tenants in the building to generate additional income.

 

The transaction is to be funded partly from cash held by the Company, partly from a commercial loan from a UK Bank over a term of five years and partly by way of a loan from the Company's Executive Chairman, Dr Mike Love, over a term of three years.

 

The loan from Dr Love is a related party transaction under AIM rules. The interest rate applicable to the loan will be 5.25 per cent above the base rate of National Westminster Bank plc and an arrangement fee will also be payable on drawdown. That fee will be a minimum of £10,000, together with an additional £6,000 if the amount drawn down exceeds £500,000 (up to the maximum amount of the loan, being £1 million). If the Company fails to repay the loan in full on or before the due date (May 2014), Dr Love shall be entitled to convert any amount outstanding into ordinary share capital, provided that:

 

(i) the aggregate nominal value of the ordinary shares to be issued does not exceed £362,581 and/or

 

(ii) the conversion will not result in Dr Love and persons acting in concert with him carrying more than a combined interest of 29.9 per cent of the voting rights in the Company. Any conversion will be by reference to the average mid market closing price of an ordinary share over the 5 business days preceding the Company receiving notice of conversion from Dr Love.

 

 

The Directors (excluding Dr Love), having consulted with SciSys' Nominated Advisor, Canaccord Genuity, are satisfied that the terms of the loan from Dr Love are fair and reasonable insofar as the Company's shareholders are concerned.  

 

Given the Company's strong balance sheet, and subject to continued satisfactory trading, it is the Directors' current intention to continue with the progressive dividend policy announced in 2009.

 

 

For further information please contact:

SciSys PLC

 

 

Mike Love

Executive Chairman

Tel : +44 (0) 1249 466 466

Chris Cheetham

Finance Director

 

 

 

 

Winningtons

Tom Cooper

Tel : +44 (0) 797 1221972

 

 

 

Canaccord Genuity

Simon Bridges

Kit Stephenson

Tel : +44 (0) 20  7050 6500

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZKZKVGMZM
Date   Source Headline
20th Jun 20195:39 pmRNSForm 8 (DD) - SCISYS
19th Jun 20195:57 pmRNSDirector Dealings
17th Jun 20192:48 pmRNSForm 8 (DD) - SCISYS Group PLC
17th Jun 20199:48 amRNSRecommended Cash Offer
14th Jun 201911:05 amRNSSecond Price Monitoring Extn
14th Jun 201911:00 amRNSPrice Monitoring Extension
14th Jun 20199:00 amRNSPrice Monitoring Extension
14th Jun 20197:29 amRNSRECOMMENDED CASH OFFER
6th Jun 20193:29 pmRNSResult of AGM
6th Jun 20197:00 amRNSAGM Statement
20th May 20191:53 pmRNSDirector/PDMR Shareholding
16th May 20198:00 amRNSEuronext Growth Dublin Notice
10th May 20194:35 pmRNSExercise of Options and Total Voting Rights
2nd May 20198:00 amRNSEuronext Growth Dublin Notice
30th Apr 20197:00 amRNSContract Win
25th Apr 20196:33 pmRNSReplacement RNS - Exercise of Options and TVR
25th Apr 20194:38 pmRNSExercise of Options and Total Voting Rights
23rd Apr 201912:32 pmRNSAnnual Report and Financial Statements
16th Apr 20194:44 pmRNSDirector/PDMR Shareholding
28th Mar 20197:00 amRNSPreliminary Results for the year ended 31 Dec 2018
25th Jan 20197:00 amRNSPre-Close Trading Update and Notice of Results
16th Jan 20197:00 amRNSContract win
10th Jan 20197:00 amRNSContract Win
3rd Jan 20197:00 amRNSContract Win
24th Dec 20187:00 amRNSContract Win
20th Dec 20181:44 pmRNSContract Win
18th Dec 20187:00 amRNSAppointment of Director
17th Dec 20187:00 amRNSContract Win
28th Nov 20188:14 amRNSFirst day of dealings
27th Nov 201812:53 pmRNSScheme Effective
27th Nov 201811:02 amRNSCourt Sanction of the Scheme
27th Nov 20187:30 amRNSSuspension - SCISYS PLC
19th Nov 201812:07 pmRNSResults of Court Meeting & Scheme General Meeting
16th Nov 20182:16 pmRNSDirector/PDMR Shareholding
29th Oct 20182:45 pmRNSIssue of Equity
26th Oct 201810:00 amRNSSchedule One - SCISYS Group PLC
26th Oct 20187:00 amRNSPosting of Scheme Document
24th Oct 20182:05 pmRNSSecond Price Monitoring Extn
24th Oct 20182:00 pmRNSPrice Monitoring Extension
23rd Oct 20185:46 pmRNSDirector Dealings
22nd Oct 20182:33 pmRNSChange of Auditor
17th Oct 201811:26 amRNSDirector Dealings
17th Oct 201811:15 amRNSBrexit Contingency Planning
27th Sep 201812:28 pmRNSDirector Dealings and Issue of Equity
20th Sep 20187:00 amRNSInterim Results
18th Sep 20187:00 amRNS£2m contract for TfL's Future Bus programme
30th Aug 20187:00 amRNSSCISYS HELPS SAVE THE UK'S SOUNDS
30th Aug 20187:00 amRNSTrading Update and Notice of Interim Results
18th Jul 20184:43 pmRNSDirector Dealings
17th Jul 20183:18 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.